Noonberg Sarah B. bought NGNE
February 20, 2026 · Form 4 insider transaction
Noonberg Sarah B. bought 12,050 shares of Neurogene Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 4 days after the transaction.
Direction
Acquired (buy-side)
Shares
12,050
Price
$0.00
Total value
N/A
InsiderNoonberg Sarah B.
Role—
CompanyNeurogene Inc. (NGNE)
SecurityNon-Qualified Stock Option (right to buy)
Transaction codeA: Grant or award
Transaction dateFebruary 20, 2026
Filing dateFebruary 24, 2026
Shares owned after12,050
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
The option vests as to 1/12 of the total shares monthly beginning March 20, 2026 until the option is fully vested on February 20, 2027, subject to the Reporting Person's provision of service to the Issuer on each vesting date.